RARE- Ultragenyx Pharmaceutical Inc.

Over the past 90 days, insiders at Ultragenyx Pharmaceutical Inc. (RARE) have been net sellers, shedding 4,653 shares worth roughly $111K on balance.

RARE sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.

Insider Ownership

Role	Insider	Shares	Value	30d
Other	Huang Dennis Karl	147.8K	$3.81M	-
Other	Pinion John Richard	133.1K	$3.43M	-
CEO	Kakkis Emil D	132.7K	$3.42M	-
CFO	Horn Howard	105.7K	$2.72M	-
VP	Parschauer Karah Herdman	95.7K	$2.47M	-

Buys and sells only

10 filings · page 20

Date	Insider	Role	Type	Shares	Price	Value	Chg%
Dec 22, 2015	Agarwal Sunil	Chief Medical Officer	Sell	498	$114.81	$57,175.38	-3.6%
Dec 18, 2015	Huizenga Theodore Alan65	Controller And Pao	Sale+OE	1,500	$110.55	$165,825.00	-37.5%
Dec 10, 2015	Sharp Shalini	CFO &Senior Vice President	Sale+OE	12,000	$101.66	$1,219,956.99	-11.9%
Nov 30, 2015	Kakkis Emil D72	President &CEO	Sell	20,000	$98.27	$1,965,426.86	-0.8%
Nov 23, 2015	Agarwal Sunil	Chief Medical Officer	Sell	498	$95.88	$47,748.24	-3.5%
Oct 30, 2015	Kakkis Emil D72	President &CEO	Sell	20,000	$99.57	$1,991,407.00	-0.8%
Oct 20, 2015	Agarwal Sunil	Chief Medical Officer	Sell	649	$85.51	$55,495.99	-4.2%
Sep 22, 2015	Agarwal Sunil	Chief Medical Officer	Sell	498	$109.51	$54,535.98	-3.0%
Aug 20, 2015	Agarwal Sunil	Chief Medical Officer	Sale+OE	17,020	$111.18	$1,892,211.88	-10.6%
Aug 12, 2015	Kassberg Thomas Richard68	Cbo &Senior Vice President	Sell	3,334	$109.70	$365,739.80	-4.5%